Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07662798 · ClinicalTrials.gov registry record · Phase 1
A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants
A Phase 1 study, sponsored by Eli Lilly and Company.
- Not yet
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT07662798 is a Phase 1 study that has not yet begun recruiting, run by Eli Lilly and Company. The registered enrollment target is 60 participants.
The verdict
NCT07662798, a Phase 1 study, has not yet begun recruiting, sponsored by Eli Lilly and Company.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The main purpose of this study is to measure how food affects the amount of tersolisib that gets into the bloodstream. Each participant will receive two single oral doses of tersolisib, one under fasted conditions and one with either a high-fat or a low-fat meal. Blood tests will be performed to investigate how the body processes the study drug under each condition. For each participant, the study will last about 9 weeks and will include a stay in the Clinical Research Unit (CRU) lasting almost a month.
Interventions
- OTHER High-fat Meal
- DRUG Tersolisib
- OTHER Low-fat Meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-07 |
| Est. Completion | 2026-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07662798
The ClinicalTrials.gov registry entry for NCT07662798 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which High-fat Meal is the first listed.
NCT07662798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07662798 about?
NCT07662798 is a clinical study titled "A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants". The main purpose of this study is to measure how food affects the amount of tersolisib that gets into the bloodstream. Each participant will receive two single oral doses of tersolisib, one under fasted conditions and one with either a high-fat or a low-fat meal. Blood tests will be performed to inv...
What is the current status of trial NCT07662798?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2026-07. Estimated completion is 2026-09.
What interventions are being tested in trial NCT07662798?
The interventions under investigation include: High-fat Meal (OTHER), Tersolisib (DRUG), Low-fat Meal (OTHER).
Who is sponsoring clinical trial NCT07662798?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.